These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 23328224)

  • 21. An acute bronchodilator test with tiotropium or salmeterol does not allow a subdivision of patients according to responses.
    Matera MG; Sanduzzi A; Ponticiello A; Vatrella A; Salzillo A; Cazzola M
    Respiration; 2005; 72(5):466-70. PubMed ID: 16210884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A dose-ranging study of indacaterol in obstructive airways disease, with a tiotropium comparison.
    Rennard S; Bantje T; Centanni S; Chanez P; Chuchalin A; D'Urzo A; Kornmann O; Perry S; Jack D; Owen R; Higgins M
    Respir Med; 2008 Jul; 102(7):1033-44. PubMed ID: 18479895
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomised controlled comparison of tiotropium nd ipratropium in the treatment of chronic obstructive pulmonary disease. The Dutch Tiotropium Study Group.
    van Noord JA; Bantje TA; Eland ME; Korducki L; Cornelissen PJ
    Thorax; 2000 Apr; 55(4):289-94. PubMed ID: 10722768
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical benefits of tiotropium, a new anticholinergic bronchodilator].
    Izquierdo Alonso JL
    An Med Interna; 2002 Dec; 19(12):640-3. PubMed ID: 12593035
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment persistence and compliance with medications for chronic obstructive pulmonary disease.
    Cramer JA; Bradley-Kennedy C; Scalera A
    Can Respir J; 2007; 14(1):25-9. PubMed ID: 17315055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bronchodilator responsiveness in patients with COPD.
    Tashkin DP; Celli B; Decramer M; Liu D; Burkhart D; Cassino C; Kesten S
    Eur Respir J; 2008 Apr; 31(4):742-50. PubMed ID: 18256071
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tiotropium: a potential replacement for ipratropium in patients with COPD.
    Shukla VK
    Issues Emerg Health Technol; 2002 Jul; (35):1-4. PubMed ID: 12195603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anticholinergic agents in asthma and COPD.
    Gross NJ
    Eur J Pharmacol; 2006 Mar; 533(1-3):36-9. PubMed ID: 16488410
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tiotropium: a new therapeutic option in asthma.
    Novelli F; Costa F; Latorre M; Malagrinò L; Celi A; Vagaggini B; Paggiaro P
    Monaldi Arch Chest Dis; 2013; 79(3-4):109-15. PubMed ID: 24761528
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomized study of tiotropium Respimat Soft Mist inhaler vs. ipratropium pMDI in COPD.
    Voshaar T; Lapidus R; Maleki-Yazdi R; Timmer W; Rubin E; Lowe L; Bateman E
    Respir Med; 2008 Jan; 102(1):32-41. PubMed ID: 17996436
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tiotropium bromide: a long-acting anticholinergic bronchodilator for the treatment of patients with chronic obstructive pulmonary disease.
    Joos GF; Brusselle G; Derom E; Pauwels R
    Int J Clin Pract; 2003 Dec; 57(10):906-9. PubMed ID: 14712894
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of replacing oxitropium with tiotropium on pulmonary function in patients with COPD: a randomized study.
    Incorvaia C; Riario-Sforza GG; Pravettoni C; Dugnani N; Paterniti F; Pessina L; Fumagalli M
    Respir Med; 2007 Mar; 101(3):476-80. PubMed ID: 16919926
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of tiotropium bromide on circadian variation in airflow limitation in chronic obstructive pulmonary disease.
    Calverley PM; Lee A; Towse L; van Noord J; Witek TJ; Kelsen S
    Thorax; 2003 Oct; 58(10):855-60. PubMed ID: 14514937
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Additive effects of transdermal tulobuterol to inhaled tiotropium in patients with COPD.
    Ichinose M; Seyama K; Nishimura M; Fukuchi Y; Nagai A; Mishima M; Kubo K;
    Respir Med; 2010 Feb; 104(2):267-74. PubMed ID: 19875277
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tiotropium: an inhaled, long-acting anticholinergic drug for chronic obstructive pulmonary disease.
    Panning CA; DeBisschop M
    Pharmacotherapy; 2003 Feb; 23(2):183-9. PubMed ID: 12587807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blinded 12-week comparison of once-daily indacaterol and tiotropium in COPD.
    Buhl R; Dunn LJ; Disdier C; Lassen C; Amos C; Henley M; Kramer B;
    Eur Respir J; 2011 Oct; 38(4):797-803. PubMed ID: 21622587
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Combination of inhaled salmeterol/fluticasone and tiotropium in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial].
    Fang LZ; Liang X; Zhang JQ; Liu L; Fu WP; Zhao ZH; Dai LM
    Zhonghua Jie He He Hu Xi Za Zhi; 2008 Nov; 31(11):811-4. PubMed ID: 19080533
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Concomitant use of ipratropium and tiotropium in chronic obstructive pulmonary disease.
    Cole JM; Sheehan AH; Jordan JK
    Ann Pharmacother; 2012 Dec; 46(12):1717-21. PubMed ID: 23170031
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tiotropium administered by a pressurized metered dose inhaler (pMDI) and spacer produces a similar bronchodilator response as that administered by a Rotahaler in adult subjects with stable moderate-to-severe COPD.
    Brashier B; Dhembare P; Jantikar A; Mahadik P; Gokhale P; Gogtay JA; Salvi SS
    Respir Med; 2007 Dec; 101(12):2464-71. PubMed ID: 17719763
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of tiotropium and formoterol on quiet breathing pattern assessed by optoelectronic plethysmography in COPD patients: a pilot study.
    Dal Negro RW; Turati C; Micheletto C; Menegoni F
    Ther Adv Respir Dis; 2012 Apr; 6(2):97-105. PubMed ID: 22250038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.